News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
LIR Life Sciences Corp. announces successful completion of comparative mouse study evaluating skin-permeation delivery of GLP/GIP-based therapies. Results presented at ENDO 2026 -
-
-